Fate Therapeutics Inc
NASDAQ:FATE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fate Therapeutics Inc
NASDAQ:FATE
|
US |
|
G
|
GMO Internet Group Inc
XMUN:IQ3
|
JP |
|
T
|
Tempore Properties SOCIMI SAU
MAD:YTEM
|
ES |
|
Solusi Bangun Indonesia Tbk PT
IDX:SMCB
|
ID |
|
Instabank ASA
OSE:INSTA
|
NO |
|
S
|
SAS AB
F:SSV2
|
SE |
|
Jericho Energy Ventures Inc
XTSX:JEV
|
CA |
|
Cryosite Ltd
ASX:CTE
|
AU |
|
SeaBird Exploration PLC
OSE:SBX
|
CY |
|
City Chic Collective Ltd
ASX:CCX
|
AU |
|
Getty Realty Corp
F:GRL
|
US |
Wall Street
Price Targets
FATE Price Targets Summary
Fate Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
FATE
is 5.04 USD
with a low forecast of 2.02 USD and a high forecast of 8.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FATE's stock price target?
Price Target
5.04
USD
According to Wall Street analysts, the average 1-year price target for
FATE
is 5.04 USD
with a low forecast of 2.02 USD and a high forecast of 8.4 USD.
What is Fate Therapeutics Inc's Revenue forecast?
Projected CAGR
3%
For the last 13 years the
compound annual growth rate for
Fate Therapeutics Inc's revenue is
7%.
The projected
CAGR
for the next 3 years is
3%.
